OpGen Inc. (NASDAQ: OPGN) raised $10.4 million in a recent funding round led by the Merck Global Health Innovation Fund, the venture capital arm of pharmaceutical giant Merck & Co.
{iframe}http://www.bizjournals.com/washington/news/2016/06/01/merck-co-venture-arm-backs-superbug-fighter-opgen.html?ana=e_wash_rdup&s=newsletter&ed=2016-06-02&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1464879944&j=73682892{/iframe}